David L. Caudell, D.V.M., Ph.D.
Assistant Professor, Pathology-Comparative Medicine
Center for Comparative Medicine Research
biotechnology, cell growth, differentiation,d, cross(mult/tnslat/inter)discip, drugs/therapeutic agents pharm, engineering/bioengineering, growth & development, health services, research/outc, hormones/cytokines/signalling, immunology/allergy/inflammatio, instrument development, metabolism, model development, vascular diseases, women's health issues
Academic: 336-716-1621 | Department: 336-716-2011
Pardee TS, Stadelman K, Jennings-Gee J, Caudell DL, Gmeiner WH. The poison oligonucleotide F10 is highly effective against acute lymphoblastic leukemia while sparing normal hematopoietic cells. Oncotarget. 2014;5(12):4170-4179.
Maglic D, Stovall DB, Cline JM, Fry EA, Mallakin A, Taneja P, Caudell DL, Willingham MC, Sui G, Inoue K. DMP1beta, a splice isoform of the tumour suppressor DMP1 locus, induces proliferation and progression of breast cancer
. J Pathol. 2014;():.
Wellons M, Owens P, Caudell D, Appt SE. Identification of antimullerian hormone protein expression in the arterial wall of premenopausal and postmenopausal monkeys [abstract]. Menopause. 2014;21(12):1334.
Cook GJ, Caudell DL, Elford HL, Pardee T. The novel ribonucleotide reductase inhibitor didox is active against AML with limited toxicities [abstract]. Blood. 2012;120(21):Abstr 1513.
For a listing of recent publications, refer to PubMed, a service provided by the National Library of Medicine.
For a list of earlier publications, visit the Carpenter Library Publication Search.